WELLS FARGO & COMPANY/MN - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 147 filers reported holding IMMUNITYBIO INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$66,847
-62.4%
39,554
-38.2%
0.00%
Q2 2023$177,789
+195.1%
63,953
+93.2%
0.00%
Q1 2023$60,247
-17.2%
33,103
+130.6%
0.00%
Q4 2022$72,769
-21.8%
14,353
-23.2%
0.00%
Q3 2022$93,000
+52.5%
18,700
+15.2%
0.00%
Q2 2022$61,000
-91.8%
16,237
-87.8%
0.00%
Q1 2022$748,000
-0.5%
133,280
+7.8%
0.00%
Q4 2021$752,000
-38.4%
123,636
-1.3%
0.00%
Q3 2021$1,220,000
-47.0%
125,207
-22.4%
0.00%
-100.0%
Q2 2021$2,304,000
+88.5%
161,367
+213.5%
0.00%
Q1 2021$1,222,00051,4670.00%
Other shareholders
IMMUNITYBIO INC shareholders Q1 2023
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders